Summary
Xing Zhao is a healthcare entrepreneur and life sciences executive based in Cambridge, MA, who has spent his career translating regenerative medicine and cell therapy research from bench to bedside. As Founder, Chairman & Global CEO of ReLive Biotechnologies and Managing Director of CO.DON, he leads companies at the intersection of clinical development, commercialization, and investment. His background spans clinical training (MD), a PhD in regenerative medicine, Harvard postdoctoral work in tissue engineering, and leadership roles that secured FDA approvals and patents for novel cell therapies. He has founded and advised venture and industry initiatives bridging US–China markets, and served on boards for diagnostics and cell therapy startups. Colleagues describe him as patient-focused with an unusual combination of surgical training, hands-on lab expertise, and deal-making experience. He consistently prioritizes patient benefit while steering early-stage technologies toward clinical and commercial impact.
7 years of coding experience
Post-Doctoral Fellowship Orthopaedic Surgery and Plastic Surgery (Tissue Engineering & Regenerative Medicine), Post-Doctoral Fellowship Orthopaedic Surgery and Plastic Surgery (Tissue Engineering & Regenerative Medicine) at Harvard Medical School
Doctor of Medicine (MD) Clinical Medicine in Xiangya School of Medicine Central South University, Doctor of Medicine (MD) Clinical Medicine in Xiangya School of Medicine Central South University at Central South University
Executive Certificate of Managing Technical Professionals and Organizations Management and Leadership, Executive Certificate of Managing Technical Professionals and Organizations Management and Leadership at MIT Sloan School of Management
Master Clinical Science (Surgery), Master Clinical Science (Surgery) at Fudan University
Doctor of Philosophy (Ph.D.) Regenerative Medicine and Life Sciences, Doctor of Philosophy (Ph.D.) Regenerative Medicine and Life Sciences at Utrecht University
English, Chinese